Immunology of SARS-CoV-2 infection in children
- PMID: 35105983
- PMCID: PMC8981222
- DOI: 10.1038/s41590-021-01123-9
Immunology of SARS-CoV-2 infection in children
Abstract
Children and adolescents exhibit a broad range of clinical outcomes from SARS-CoV-2 infection, with the majority having minimal to mild symptoms. Additionally, some succumb to a severe hyperinflammatory post-infectious complication called multisystem inflammatory syndrome in children (MIS-C), predominantly affecting previously healthy individuals. Studies characterizing the immunological differences associated with these clinical outcomes have identified pathways important for host immunity to SARS-CoV-2 and innate modulators of disease severity. In this Review, we delineate the immunological mechanisms underlying the spectrum of pediatric immune response to SARS-CoV-2 infection in comparison with that of adults.
© 2022. Springer Nature America, Inc.
Conflict of interest statement
Competing interests statement
P.G.T. serves on the Scientific Advisory Board of Immunoscape and Cytoagents. The other authors declare no competing interests.
Figures



References
Publication types
MeSH terms
Supplementary concepts
Grants and funding
- R01DK130465/U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
- HHSN272201400006C/AI/NIAID NIH HHS/United States
- U01 AI144616/AI/NIAID NIH HHS/United States
- 75N93019C00052/AI/NIAID NIH HHS/United States
- R01AI139633-04S1/U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous